Poly Medicure Ltd.
NSE: POLYMED · Medical Equipment & Supplies
Snapshot
Unlock Poly Medicure Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Poly Medicure Limited is a manufacturer and exporter of high-quality medical devices, specialising in infusion therapy, oncology, respiratory care, and dialysis products. The company provides a comprehensive range of disposable medical equipment for hospitals and clinical settings globally.
Business Model
The company generates revenue through the large-scale manufacturing and sale of medical consumables and devices to healthcare providers and distributors. It operates on a high-volume production model, leveraging an extensive product portfolio to serve both domestic and international markets.
- Incorporation Year:1995
Growth Outlook
Growth is driven by the expansion of the company's diverse product portfolio into specialised areas such as oncology and dialysis systems. Continued investment in manufacturing capabilities supports its ability to meet rising global demand for medical disposables.
Key Risks
- Regulatory Compliance. The company faces risks related to stringent international quality standards and regulatory approvals required for medical device exports.
- Input Cost Volatility. Fluctuations in the prices of raw materials, such as medical-grade polymers and plastics, can impact manufacturing margins.
- Competitive Pressure. The medical device sector is highly competitive, requiring constant innovation and cost-efficiency to maintain market share against global players.
- Foreign Exchange Risk. As a significant exporter, the company is exposed to currency volatility which may affect its international revenue realisations.
Start your research today
Unlock AI insights, financials, peers and live data on Poly Medicure Ltd. and 5,000+ companies — free.
Key Metrics
REVENUE
₹1,997 Cr
TTM · consolidated
NET PROFIT
₹313 Cr
TTM · consolidated
EPS
₹31.09
TTM · consolidated
RETURN ON EQUITY
10.7%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
14.2%
TTM · consolidated
P/E
54.8x
Q1 FY27 · consolidated
EV/EBITDA
30.6x
Q1 FY27 · consolidated
EBITDA MARGIN
28.7%
TTM · consolidated
NET PROFIT MARGIN
16.2%
Q1 FY27 · consolidated
DEBT TO EQUITY
0.1x
Q1 FY27 · consolidated
Peers · Medical Equipment & Supplies
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Poly Medicure Ltd.POLYMED | ₹17,256 Cr | 54.76 | 30.64 | 18.3% | 28.7% | 10.7% | 14.2% | -16.3% |
Fischer Medical Ventures LimitedFISCHER | ₹2,337 Cr | 15.02 | 42.51 | 196.0% | 15.4% | 7.7% | 12.8% | -96.7% |
Tarsons ProductsTARSONS | ₹1,785 Cr | 160.55 | 14.69 | 10.6% | 33.1% | 1.8% | 4.5% | +4.0% |
Laxmi DentalLAXMIDENTL | ₹1,095 Cr | 35.18 | 19.76 | — | 19.2% | 13.7% | 13.3% | -40.1% |
Vasa Denticity LimitedDENTALKART | ₹715 Cr | — | — | — | 3.9% | — | — | -32.9% |
Hemant Surgical Industries LimitedHSIL | ₹541 Cr | — | — | — | 10.0% | — | — | +23.3% |
As of Q1 FY27
Financials
Poly Medicure Ltd.
NSE: POLYMED · Medical Equipment & Supplies
Snapshot
Unlock Poly Medicure Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Poly Medicure Limited is a manufacturer and exporter of high-quality medical devices, specialising in infusion therapy, oncology, respiratory care, and dialysis products. The company provides a comprehensive range of disposable medical equipment for hospitals and clinical settings globally.
Business Model
The company generates revenue through the large-scale manufacturing and sale of medical consumables and devices to healthcare providers and distributors. It operates on a high-volume production model, leveraging an extensive product portfolio to serve both domestic and international markets.
- Incorporation Year:1995
Growth Outlook
Growth is driven by the expansion of the company's diverse product portfolio into specialised areas such as oncology and dialysis systems. Continued investment in manufacturing capabilities supports its ability to meet rising global demand for medical disposables.
Key Risks
- Regulatory Compliance. The company faces risks related to stringent international quality standards and regulatory approvals required for medical device exports.
- Input Cost Volatility. Fluctuations in the prices of raw materials, such as medical-grade polymers and plastics, can impact manufacturing margins.
- Competitive Pressure. The medical device sector is highly competitive, requiring constant innovation and cost-efficiency to maintain market share against global players.
- Foreign Exchange Risk. As a significant exporter, the company is exposed to currency volatility which may affect its international revenue realisations.
Start your research today
Unlock AI insights, financials, peers and live data on Poly Medicure Ltd. and 5,000+ companies — free.
Key Metrics
REVENUE
₹1,997 Cr
TTM · consolidated
NET PROFIT
₹313 Cr
TTM · consolidated
EPS
₹31.09
TTM · consolidated
RETURN ON EQUITY
10.7%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
14.2%
TTM · consolidated
P/E
54.8x
Q1 FY27 · consolidated
EV/EBITDA
30.6x
Q1 FY27 · consolidated
EBITDA MARGIN
28.7%
TTM · consolidated
NET PROFIT MARGIN
16.2%
Q1 FY27 · consolidated
DEBT TO EQUITY
0.1x
Q1 FY27 · consolidated
Peers · Medical Equipment & Supplies
As of Q1 FY27